Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • 2025
  • October
  • Page 52
oxford-biodynamics-unveils-new-target-use-for-episwitch-blood-test
Posted inMedical Technology

Oxford BioDynamics unveils new target use for EpiSwitch blood test

October 8, 2025
Oxford BioDynamics, a U.K.-based maker of precision diagnostics, touted progress toward a first-of-its-kind blood test for chronic fatigue syndrome (CFS)—also…
Read More
arthrosi-raises-$153m,-fueling-dash-toward-phase-3-gout-data-in-2026
Posted inBiotechnology

Arthrosi raises $153M, fueling dash toward phase 3 gout data in 2026

October 8, 2025
Arthrosi Therapeutics has raised $153 million to bankroll its bid to clout gout. The series E financing gives the biotech the…
Read More
transcode-rewrites-future,-securing-$25m-lifeline-and-phase-3-cancer-vaccine
Posted inBiotechnology

TransCode rewrites future, securing $25M lifeline and phase 3 cancer vaccine

October 8, 2025
In a pair of deals, TransCode Therapeutics has bagged Polynoma and its phase 3 cancer vaccine, as well as a…
Read More
immunology-biotech-nilo-launches-with-$101m-and-mission-to-harness-neural-circuits
Posted inBiotechnology

Immunology biotech Nilo launches with $101M and mission to harness neural circuits

October 8, 2025
Nilo Therapeutics has launched with $101 million in series A funds to drive its ambition to harness neural circuits to…
Read More
sanofi’s-$110m-radioligand-therapy-hits-response-rate-goal-in-phase-2-tumor-trial
Posted inBiotechnology

Sanofi’s $110M radioligand therapy hits response rate goal in phase 2 tumor trial

October 8, 2025
Sanofi’s $110 million bet on a radioligand seems to be paying off after the neuroendocrine tumor treatment hit the key endpoints…
Read More
alpenglow-teams-up-with-virdx-to-boost-prostate-cancer-diagnosis-with-nvidia,-ai-power
Posted inMedical Technology

Alpenglow teams up with Virdx to boost prostate cancer diagnosis with Nvidia, AI power

October 8, 2025
Alpenglow Biosciences has penned a new, multiyear strategic agreement with Virdx to create the next generation of artificial-intelligence-powered tools aimed…
Read More
after-high-profile-fda-exit,-peter-marks-lands-at-eli-lilly
Posted inBiotechnology

After high-profile FDA exit, Peter Marks lands at Eli Lilly

October 7, 2025
Peter Marks, M.D., Ph.D., the former head of the FDA’s Center for Biologics Evaluation and Research (CBER), has joined Eli…
Read More
us-government-earmarks-up-to-$48m-for-development-of-kernal’s-mrna-car-t
Posted inBiotechnology

US government earmarks up to $48M for development of Kernal’s mRNA CAR-T

October 7, 2025
The U.S. government has awarded Kernal Bio and three other sub-awardees up to $48 million to help advance the biotech’s…
Read More
langer-family-rna-biotech-souffle-rises-with-$200m-and-big-pharma-partners
Posted inBiotechnology

Langer family RNA biotech Soufflé rises with $200M and Big Pharma partners

October 7, 2025
A new RNA biotech has risen with a $200 million series A in the tank and a team of seasoned…
Read More
learn-strategies-to-address-pfas-challenges-facing-the-medical-device-industry.
Posted inBiotechnology

Learn strategies to address PFAS challenges facing the medical device industry.

October 7, 2025
In recent years, the presence of per- and poly-fluoroalkyl substances (PFAS), commonly known as "forever chemicals," in medical devices has…
Read More

Posts pagination

Previous page 1 … 50 51 52 53 54 Next page

Privacy Policy    Terms

Scroll to Top